320 related articles for article (PubMed ID: 31422111)
1. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction.
Núñez J; Llàcer P; García-Blas S; Bonanad C; Ventura S; Núñez JM; Sánchez R; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Chamorro C; Bodi V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Rodríguez E; Mollar A; Palau P; Bosch MJ; Bertomeu-González V; Lupón J; Navarro J; Chorro FJ; Górriz JL; Sanchis J; Voors AA; Bayés-Genís A
Am J Med; 2020 Mar; 133(3):370-380.e4. PubMed ID: 31422111
[TBL] [Abstract][Full Text] [Related]
2. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
[TBL] [Abstract][Full Text] [Related]
3. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
6. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
[TBL] [Abstract][Full Text] [Related]
8. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
[TBL] [Abstract][Full Text] [Related]
9. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
[TBL] [Abstract][Full Text] [Related]
10. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
12. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
[TBL] [Abstract][Full Text] [Related]
13. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
Hanberg JS; Tang WHW; Wilson FP; Coca SG; Ahmad T; Brisco MA; Testani JM
Int J Cardiol; 2017 Aug; 241():277-282. PubMed ID: 28392080
[TBL] [Abstract][Full Text] [Related]
14. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
[TBL] [Abstract][Full Text] [Related]
15. Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF).
Schulze PC; Bogoviku J; Westphal J; Aftanski P; Haertel F; Grund S; von Haehling S; Schumacher U; Möbius-Winkler S; Busch M
Circulation; 2022 Jul; 146(4):289-298. PubMed ID: 35766022
[TBL] [Abstract][Full Text] [Related]
16. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
Chen HH; Anstrom KJ; Givertz MM; Stevenson LW; Semigran MJ; Goldsmith SR; Bart BA; Bull DA; Stehlik J; LeWinter MM; Konstam MA; Huggins GS; Rouleau JL; O'Meara E; Tang WH; Starling RC; Butler J; Deswal A; Felker GM; O'Connor CM; Bonita RE; Margulies KB; Cappola TP; Ofili EO; Mann DL; Dávila-Román VG; McNulty SE; Borlaug BA; Velazquez EJ; Lee KL; Shah MR; Hernandez AF; Braunwald E; Redfield MM;
JAMA; 2013 Dec; 310(23):2533-43. PubMed ID: 24247300
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
18. Diuretic strategies in patients with acute decompensated heart failure.
Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
[TBL] [Abstract][Full Text] [Related]
19. Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
Palazzuoli A; Pellegrini M; Franci B; Beltrami M; Ruocco G; Gonnelli S; Angelini GD; Nuti R
Intern Emerg Med; 2015 Feb; 10(1):41-9. PubMed ID: 25087085
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Matsue Y; Suzuki M; Nagahori W; Yoshida K; Onishi Y; Satoh Y; Ono Y; Nishioka T; Noda M; Sugi K; Torii S; Tejima T; Sakurada H; Yamaguchi S; Okishige K; Fujii H; Takahashi A
Cardiovasc Drugs Ther; 2014 Feb; 28(1):73-7. PubMed ID: 24048511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
